Bingfeng Han

3.2k total citations · 4 hit papers
34 papers, 1.6k citations indexed

About

Bingfeng Han is a scholar working on Epidemiology, Oncology and Health. According to data from OpenAlex, Bingfeng Han has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Oncology and 10 papers in Health. Recurrent topics in Bingfeng Han's work include Global Cancer Incidence and Screening (10 papers), Vaccine Coverage and Hesitancy (10 papers) and Hepatitis B Virus Studies (8 papers). Bingfeng Han is often cited by papers focused on Global Cancer Incidence and Screening (10 papers), Vaccine Coverage and Hesitancy (10 papers) and Hepatitis B Virus Studies (8 papers). Bingfeng Han collaborates with scholars based in China, United States and Taiwan. Bingfeng Han's co-authors include Rongshou Zheng, Hongmei Zeng, Jie He, Wenqiang Wei, Ru Chen, Kexin Sun, Shaoming Wang, Li Li, Shaoming Wang and Wenqiang Wei and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Cancer.

In The Last Decade

Bingfeng Han

30 papers receiving 1.6k citations

Hit Papers

Cancer incidence and mortality in China, 2022 2024 2026 2025 2024 2024 2024 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer incidence and mortality in China, 2022
    2024 866 citations Bingfeng Han, Rongshou Zheng et al. SHILAP Revista de lepidopterología profile →
  2. [Cancer incidence and mortality in China, 2022].
    2024 223 citations Rongshou Zheng, Bingfeng Han et al. PubMed profile →
  3. Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN
    2024 102 citations Shaoming Wang, Rongshou Zheng et al. ˜The œLancet. Gastroenterology & hepatology profile →
  4. Cancer survival statistics in China 2019–2021: a multicenter, population-based study
    2024 50 citations Hongmei Zeng, Rongshou Zheng et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingfeng Han China 13 509 382 349 217 213 34 1.6k
Jinqiu Yuan China 24 623 1.2× 357 0.9× 417 1.2× 229 1.1× 256 1.2× 99 2.0k
Aaron J. Scott United States 18 502 1.0× 232 0.6× 287 0.8× 151 0.7× 181 0.8× 87 1.2k
Joseph S. Koopmeiners United States 28 273 0.5× 499 1.3× 535 1.5× 233 1.1× 143 0.7× 109 2.2k
Milena Ilić Serbia 18 979 1.9× 396 1.0× 513 1.5× 393 1.8× 299 1.4× 105 2.3k
Irena Ilić Serbia 14 896 1.8× 339 0.9× 472 1.4× 354 1.6× 265 1.2× 73 2.0k
Yizhou Jiang United States 22 1.0k 2.0× 392 1.0× 465 1.3× 149 0.7× 128 0.6× 93 1.9k
Qing Gong China 15 538 1.1× 185 0.5× 517 1.5× 135 0.6× 307 1.4× 40 3.4k
Abha G. Singh United States 14 243 0.5× 299 0.8× 414 1.2× 312 1.4× 663 3.1× 29 2.5k
Mark J. Rutherford United Kingdom 23 726 1.4× 384 1.0× 290 0.8× 225 1.0× 299 1.4× 90 2.0k
Seri Hong South Korea 19 549 1.1× 434 1.1× 297 0.9× 185 0.9× 253 1.2× 47 1.5k

Countries citing papers authored by Bingfeng Han

Since Specialization
Citations

This map shows the geographic impact of Bingfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingfeng Han more than expected).

Fields of papers citing papers by Bingfeng Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingfeng Han. The network helps show where Bingfeng Han may publish in the future.

Co-authorship network of co-authors of Bingfeng Han

This figure shows the co-authorship network connecting the top 25 collaborators of Bingfeng Han. A scholar is included among the top collaborators of Bingfeng Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingfeng Han. Bingfeng Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Qian, Yifei Yao, Ru Chen, et al.. (2025). Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022. Science China Life Sciences. 68(5). 1478–1486. 3 indexed citations
2.
Sun, Kexin, et al.. (2025). Cervical cancer burden and trends in China, 2000–2020: Asia-Pacific international comparisons and insights for elimination goals. Cancer Biology and Medicine. 22(9). 1017–1035. 2 indexed citations
3.
4.
Sun, Kexin, Bingfeng Han, Hongmei Zeng, et al.. (2024). Incidence and Mortality of Cancers in Female Genital Organs — China, 2022. China CDC Weekly. 6(10). 195–202. 15 indexed citations
5.
Zeng, Hongmei, Rongshou Zheng, Kexin Sun, et al.. (2024). Cancer survival statistics in China 2019–2021: a multicenter, population-based study. SHILAP Revista de lepidopterología. 4(3). 203–213. 50 indexed citations breakdown →
6.
Han, Bingfeng, Rongshou Zheng, Hongmei Zeng, et al.. (2024). Cancer incidence and mortality in China, 2022. SHILAP Revista de lepidopterología. 4(1). 47–53. 866 indexed citations breakdown →
7.
Wang, Shaoming, Rongshou Zheng, Jiayue Li, et al.. (2024). Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN. ˜The œLancet. Gastroenterology & hepatology. 9(3). 229–237. 102 indexed citations breakdown →
8.
Wang, Shaoming, Rongshou Zheng, Jianhua Gu, et al.. (2024). Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050. The Lancet Regional Health - Western Pacific. 44. 101003–101003. 26 indexed citations
9.
Zhang, Bailin, Shaoyuan Lei, Rongshou Zheng, et al.. (2024). Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022. Chinese Medical Journal. 137(20). 2429–2436. 12 indexed citations
10.
Zhao, Tianshuo, Chao Wang, Sihui Zhang, et al.. (2023). What Causes the Discrepancy in SARS-CoV-2 Vaccine Between Parental Hesitancy for Themselves and for Their Children During Lockdown Period?. Journal of Epidemiology and Global Health. 13(3). 422–434. 1 indexed citations
11.
Zheng, Rongshou, Hongmei Zeng, Siwei Zhang, et al.. (2023). Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1284–1293. 2 indexed citations
12.
Zeng, Hongmei, Rongshou Zheng, Kexin Sun, et al.. (2023). Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population‐based study. International Journal of Cancer. 154(3). 477–487. 5 indexed citations
13.
14.
15.
16.
Han, Bingfeng, Wu Liu, Juan Du, et al.. (2021). Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial. Vaccine. 39(25). 3365–3371. 6 indexed citations
17.
Wang, Chao, Bingfeng Han, Tianshuo Zhao, et al.. (2021). Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study. Vaccine. 39(21). 2833–2842. 125 indexed citations
18.
Han, Bingfeng, Qianli Yuan, Jiang Liu, et al.. (2020). [Studies on sexual and childbearing-related stigma against chronic hepatitis B patients in four provinces in China].. PubMed. 41(4). 504–507.
19.
Han, Bingfeng, Shuai Wang, Jiang Liu, et al.. (2019). Has the public lost confidence in vaccines because of a vaccine scandal in China. Vaccine. 37(36). 5270–5275. 25 indexed citations
20.
Han, Bingfeng, Qianli Yuan, Yuhui Shi, et al.. (2018). The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China. PLoS ONE. 13(4). e0195455–e0195455. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinqiu Yuan Breakdown of academic impact, for papers by Aaron J. Scott Breakdown of academic impact, for papers by Joseph S. Koopmeiners Breakdown of academic impact, for papers by Milena Ilić Breakdown of academic impact, for papers by Irena Ilić Breakdown of academic impact, for papers by Yizhou Jiang Breakdown of academic impact, for papers by Qing Gong Breakdown of academic impact, for papers by Abha G. Singh Breakdown of academic impact, for papers by Mark J. Rutherford Breakdown of academic impact, for papers by Seri Hong
Rankless by CCL
2026